Search the Newsreel

Veradermics (MANE) Q1 2026 Earnings: Wider-than-Expected Loss Triggers Stock Decline - Strong Earnings Momentum

Why The Trade Desk (TTD) Shares Are Plunging Today

Why The Trade Desk (TTD) Shares Are Plunging Today What Happened? Shares of digital advertising platform The Trade Desk (NASDAQ:TTD) fell 21.1% in the afternoon session after the company reported a weak second-quarter earnings report and a third-quarter outlook. The company reported Q2 2026 …

Palisade Bio plans phase 2 ulcerative colitis trial in 2H 2026

Palisade Bio (NASDAQ:PALI) announced plans to initiate a Phase 2 clinical trial for its drug candidate PALI-2108 in ulcerative colitis during the second half of 2026, with results expected in late 2027. The company also intends to file an investigational new drug application for …

Palisade Bio (NASDAQ:PALI) Releases Quarterly Earnings Results, Hits Expectations

Palisade Bio (NASDAQ:PALI) announced its quarterly earnings, reporting a loss of $0.05 per share, which met analyst expectations, and revenue of $0.50 million. The stock saw a slight dip, trading down 0.5% to $2.10, while analysts maintain an overall "Buy" rating with a target …

Palisade Bio Q2 Results: Net loss widens to $10.6 million on R&D surge

Palisade Bio (NASDAQ: PALI) reported a Q2 2026 net loss of $10.6 million, significantly wider than the $2.8 million loss in Q2 2025, primarily due to increased R&D expenses for its lead candidate, PALI-2108. Despite the widening loss, the company's EPS of $(0.05) met …

Cadence Design Systems Inc. stock underperforms Monday when compared to competitors

Cadence Design Systems Inc. (CDNS) stock fell 2.16% on Monday, underperforming the broader market. This drop occurred despite the S&P 500 Index and Dow Jones Industrial Average experiencing only slight declines. The stock's fall ended a two-day winning streak.

PALISADE BIO, INC. Q2 2026: Revenue $0.5M, EPS $(0.05) — 10-Q Summary

PALISADE BIO, INC. (PALI) reported second-quarter 2026 financial results with $0.5 million in revenue and a net loss of $10.6 million, or $(0.05) diluted EPS. This marks an increase in revenue compared to the year-ago quarter, though the net loss widened. The company also …

Palisade Bio expects once-daily drug trial for bowel disease to start in 2H

Palisade Bio reported Q2 2026 financial results, including a net loss of $10.6 million, and provided an update on its lead Inflammatory Bowel Disease (IBD) candidate, PALI-2108. The company plans to initiate Phase 2 ASCENTRA-UC trials for ulcerative colitis in the second half of …

Academy Sports partners with Instacart for same-day delivery in as fast as one hour

Academy Sports & Outdoors has partnered with Instacart to provide same-day delivery services, with orders fulfilled in as fast as one hour. This collaboration expands Academy's omnichannel reach to over 300 stores across 21 states, allowing customers to access their full product assortment through …

Banco Bradesco Sa (BBD) Stock Forecasts

Cascades (TSE:CAS) Stock Price Expected to Rise, Desjardins Analyst Says

Royal Bank Of Canada Issues Positive Forecast for Cascades (TSE:CAS) Stock Price

La caída de las acciones de The Trade Desk se profundiza tras resultados débiles en el segundo trimestre de 2026

Trade Desk (TTD) Stock Is Falling Today: What's Behind the Drop, and Are Its Peers Moving Too?

Palisade Bio Reports Second Quarter 2026 Financial Results

Palisade Bio, Inc. reported its second-quarter 2026 financial results, highlighting the continued advancement of PALI-2108 into Phase 2 development for inflammatory bowel disease (IBD). The company expects to begin enrollment for the Phase 2 ASCENTRA-UC trial in the second half of 2026, with primary …

Wedbush raises Jade Biosciences price target on pipeline progress

Wedbush has increased its price target for Jade Biosciences (NASDAQ:JBIO) to $47 from $45, maintaining an Outperform rating due to consistent pipeline progress. The firm highlighted positive data for JADE101 in IgAN patients and announced a new program, JADE301, targeting dermatomyositis, expected to enter …

Cadeler Orders Two Giant Offshore Wind Installation Vessels in $938 Million Fleet Expansion

Cadeler has placed firm orders for two new T-class offshore wind installation vessels with COSCO Shipping Offshore in China, valued at approximately $938 million. These vessels, scheduled for delivery in 2030 and 2031, are designed to handle the increasingly large turbines and complex projects …

Why The Trade Desk Was Sliding Again Today

Shares of The Trade Desk (NASDAQ: TTD) were falling again on Monday as Wall Street reactions to last week's dismal earnings report rolled in. As of 9:55 a.m. ET, the stock was down 4.7% on the news. Missed Nvidia in 2009? This Rare Signal …

Leader Education Reschedules Extraordinary General Meeting and Adjusts Shareholder Record Dates

Jade Reports Wider Loss In Q2, Expects Autoimmune Pipeline Interim Data In FY27

(RTTNews) - Jade Biosciences, Inc. (JBIO), a clinical-stage biotechnology company developing therapies for autoimmune diseases, reported a wider net loss for the second quarter ended June 30, 2026, primarily reflecting research and development expenses that more than doubled from the prior year and higher …

Jade Biosciences Announces Q2 2026 Financial Results Highlighting Increased R&D and Asset Growth

Jade Biosciences, Inc. has filed its quarterly report for Q2 2026, revealing a net loss of $96.1 million for the first half of the year. The company's total assets stood at $472.1 million as of June 30, 2026. The financial results highlight increased research …

The Trade Desk Stock (TTD) Opinions on Earnings Miss and Guidance Cut

The Trade Desk crash exposed a much bigger problem

The Trade Desk (TTD) has reported the kind of profits that could shift how Wall Street values a growth stock permanently. The digital-advertising company's shares plunged roughly 22% on Aug. 7, according to Barron's, falling to their lowest level since January 2019 and becoming …

Instacart and Academy Sports + Outdoors Team Up for Same-Day Delivery in as Fast as an Hour

Customers can now shop Academy's national and exclusive private brands across sports, outdoor, apparel, footwear and more at no markups SAN FRANCISCO and KATY, Texas, Aug. 10, 2026 /PRNewswire/ -- Instacart (Nasdaq: CART), the leading grocery technology company in North America, today announced a …

Jade Biosciences Q2 Results: EPS Misses Estimate, Losses Widen

Jade Biosciences reported Q2 EPS of $(0.76), missing the analyst estimate of $(0.64) by 18.75%. This result indicates a widening of operational deficits, with a 11.63% increase in losses compared to the prior year's $(0.86) per share loss. The company's financial performance highlights challenges …

Cadeler and COSCO Shipping sign contract for two T-class installation vessels

Cadeler has signed an €805 million contract with COSCO Shipping Offshore Shipyard for the construction of two T-class offshore wind installation vessels, following a €175 million equity financing round. These vessels are designed to be among the largest and most capable in the market, …

Earnings Flash (JBIO) Jade Biosciences Posts Q2 Loss $0.76 a Share, vs. FactSet Est of $0.63 Loss

Jade Biosciences (NASDAQ: JBIO) boosts cash to $461M while loss widens

Jade Biosciences reports $55.8 million Q2 net loss

Jade Biosciences (JBIO) reported a Q2 2026 net loss of $55.8 million, an increase from $32.1 million a year prior. Despite the loss, the company holds $461.2 million in cash and expects its runway to extend into Q4 2028. The biotechnology firm provided updates …

Weekly Recap: 2Q26 recurring net income R$7.1B and mean 12-month PT $5.10

Banco Bradesco SA (BBD) reported strong 2Q26 recurring net income of R$7.1 billion, driven by loan growth, a strong insurance sector, and increased efficiency, leading to a 10.3% revenue increase and a 16.2% ROAE. Analysts maintain a mean 12-month price target of $5.10, suggesting …

Jade Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Jade Biosciences announced its second quarter 2026 financial results and provided a corporate update, highlighting positive interim Phase 1 results for JADE101 in IgA nephropathy and the initiation of a Phase 2 trial. The company also reported progress in its pipeline with JADE201 for …

News Content Hub - Cadeler firms-up COSCO deal for two foundation installation vessels

Cadeler has finalized contracts with COSCO Shipping Offshore shipyard for the construction of two T-class offshore wind installation vessels, scheduled for delivery in 2030 and 2031. These vessels are designed to be the largest and most capable in the market, incorporating advanced technologies to …

Renaissance Technologies LLC Lowers Stake in Palisade Bio, Inc. $PALI

Renaissance Technologies LLC decreased its stake in Palisade Bio, Inc. by 39% in the first quarter, selling 928,100 shares but still owning 1.45 million shares valued at approximately $2.55 million. Despite this, institutional investors collectively hold 11.79% of PALI, and analysts maintain a consensus …

Cadeler Invests in Next-Generation Vessels as Offshore Wind Projects Grow

Cadeler is expanding its fleet with two new T-class vessels to meet the growing demands of the offshore wind installation market. These vessels, developed in collaboration with COSCO Shipping Offshore shipyard, represent a significant investment of approximately EUR 805 million and are designed to …

Cadeler orders two new offshore wind installation vessels for EUR 805m

Cadeler has placed an order for two new offshore wind installation vessels, with a total investment of EUR 805 million. This move is part of the company's strategy to expand its fleet and capabilities in the growing offshore wind sector. The new vessels are …

Cadeler strengthens future installation capacity with firm orders for two T-class vessels

Cadeler has signed firm contracts with COSCO Shipping Offshore shipyard for the construction of two new T-class offshore wind installation vessels. Continue Reading